Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of BNT162b2 Annual Updated Formulations, Using Administrative Claims Data Tokenized to State Vaccine Registries

NCT06923137 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06923137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06923137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of BNT162b2 Annual Updated Formulations, Using Administrative Claims Data Tokenized to State Vaccine Registries
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
April 16, 2025
Completion date
October 31, 2030
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019 (covid-19), covid-19, covid-19 (coronavirus disease 2019), covid-19 infection, covid-19 sars-cov-2 infection, covid-19 vaccination, covid-19 vaccines, sars-cov-2 infection, covid-19, sars-cov-2 infection, covid19